Vetoquinol SA

€88.40As of Sun 8 Nov 2026, 12:00 UTC
EPA:VETOHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR 7.72%
Div yield 1.05%
ROE 10.68%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.77
PE TTM 16.23
TSR TTM 20.12%
Mkt cap €1.027B
ROIC 15.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€89
1.02%
(50.14%)
Hold 5|0|2|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share€
1.55
1.71
1.85
1.93
20.49%
26.55%
30.47%
25.05%
Revenue€M
57.14
59.76
61.98
61.28
5.92%
4.59%
8.28%
8.87%
Peers (US$1.154B)
Cap (US$)
PE
14.61B
25.72x
388.0M
13.19x
85.49M
—
1.175B
23.26x
Capital
TTM
5Y
10Y
Leveragex
0.707
1.530
1.217
EBIT/Intx
2.017
0.244
0.268
Own earn%
84.08
(24.34)
(6.12)
Sh yield%
45.66
32.31
27.27
Owners
Insiders/Inst%
3.96
35.86
Short interest%
3.90
SBC / revenue%
3.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
14–23
$1 testx
—
Incr. ROIC%
1